載入...
Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement
PURPOSE: To develop recommendations for clinical trial reporting that address the unique efficacy, toxicity, and combination and sequencing aspects of immuno-oncology (IO) treatments. METHODS: ASCO and the Society for Immunotherapy of Cancer (SITC) convened a working group that consisted of practici...
Na minha lista:
| 發表在: | J Clin Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Clinical Oncology
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6354771/ https://ncbi.nlm.nih.gov/pubmed/30339040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00145 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|